N-[2-[4-[[(3S,4S)-4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3-fluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-2-methyl-1,3-oxazole-4-carboxamide

C37H41FN8O5 — CID 176641309

IUPACN-[2-[4-[[(3S,4S)-4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3-fluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-2-methyl-1,3-oxazole-4-carboxamide
SMILESCc1nc(C(=O)Nc2ccc3nn(C4CCC(CN5CC[C@@H](c6cccc7c6n(C)c(=O)n7C6CCC(=O)NC6=O)[C@H](F)C5)CC4)cc3c2)co1
InChIInChI=1S/C37H41FN8O5/c1-21-39-30(20-51-21)35(48)40-24-8-11-29-23(16-24)18-45(42-29)25-9-6-22(7-10-25)17-44-15-14-26(28(38)19-44)27-4-3-5-31-34(27)43(2)37(50)46(31)32-12-13-33(47)41-36(32)49/h3-5,8,11,16,18,20,22,25-26,28,32H,6-7,9-10,12-15,17,19H2,1-2H3,(H,40,48)(H,41,47,49)/t22?,25?,26-,28+,32?/m0/s1
InChIKeyBZOITCCXTOTVEP-SOIACLJCSA-N
MW696.78 g/mol
LogP4.78
Rot. Bonds7

About N-[2-[4-[[(3S,4S)-4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3-fluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-2-methyl-1,3-oxazole-4-carboxamide

N-[2-[4-[[(3S,4S)-4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3-fluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-2-methyl-1,3-oxazole-4-carboxamide (PubChem CID 176641309) has the molecular formula C37H41FN8O5 and a molecular weight of 696.78 g/mol. Its IUPAC name is N-[2-[4-[[(3S,4S)-4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3-fluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-2-methyl-1,3-oxazole-4-carboxamide.

Molecular Properties

Compound NameN-[2-[4-[[(3S,4S)-4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3-fluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-2-methyl-1,3-oxazole-4-carboxamide
PubChem CID176641309
Molecular FormulaC37H41FN8O5
Molecular Weight696.78 g/mol
Exact Mass696.32
IUPAC NameN-[2-[4-[[(3S,4S)-4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3-fluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-2-methyl-1,3-oxazole-4-carboxamide
SMILESCc1nc(C(=O)Nc2ccc3nn(C4CCC(CN5CC[C@@H](c6cccc7c6n(C)c(=O)n7C6CCC(=O)NC6=O)[C@H](F)C5)CC4)cc3c2)co1
InChIInChI=1S/C37H41FN8O5/c1-21-39-30(20-51-21)35(48)40-24-8-11-29-23(16-24)18-45(42-29)25-9-6-22(7-10-25)17-44-15-14-26(28(38)19-44)27-4-3-5-31-34(27)43(2)37(50)46(31)32-12-13-33(47)41-36(32)49/h3-5,8,11,16,18,20,22,25-26,28,32H,6-7,9-10,12-15,17,19H2,1-2H3,(H,40,48)(H,41,47,49)/t22?,25?,26-,28+,32?/m0/s1
InChIKeyBZOITCCXTOTVEP-SOIACLJCSA-N
XLogP4.78
TPSA149.29 Ų
H-Bond Donors2
H-Bond Acceptors11
Rotatable Bonds7
Heavy Atoms51
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500696.78
LogP ≤ 54.78
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze N-[2-[4-[[(3S,4S)-4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3-fluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-2-methyl-1,3-oxazole-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[2-[4-[[(3S,4S)-4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3-fluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-2-methyl-1,3-oxazole-4-carboxamide?
The IUPAC name of N-[2-[4-[[(3S,4S)-4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3-fluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-2-methyl-1,3-oxazole-4-carboxamide (CID 176641309) is N-[2-[4-[[(3S,4S)-4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3-fluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-2-methyl-1,3-oxazole-4-carboxamide.
What is the SMILES notation for N-[2-[4-[[(3S,4S)-4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3-fluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-2-methyl-1,3-oxazole-4-carboxamide?
The canonical SMILES for N-[2-[4-[[(3S,4S)-4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3-fluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-2-methyl-1,3-oxazole-4-carboxamide is Cc1nc(C(=O)Nc2ccc3nn(C4CCC(CN5CC[C@@H](c6cccc7c6n(C)c(=O)n7C6CCC(=O)NC6=O)[C@H](F)C5)CC4)cc3c2)co1.
What is the InChIKey of N-[2-[4-[[(3S,4S)-4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3-fluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-2-methyl-1,3-oxazole-4-carboxamide?
The InChIKey is BZOITCCXTOTVEP-SOIACLJCSA-N. The full InChI is InChI=1S/C37H41FN8O5/c1-21-39-30(20-51-21)35(48)40-24-8-11-29-23(16-24)18-45(42-29)25-9-6-22(7-10-25)17-44-15-14-26(28(38)19-44)27-4-3-5-31-34(27)43(2)37(50)46(31)32-12-13-33(47)41-36(32)49/h3-5,8,11,16,18,20,22,25-26,28,32H,6-7,9-10,12-15,17,19H2,1-2H3,(H,40,48)(H,41,47,49)/t22?,25?,26-,28+,32?/m0/s1.
What are the key properties of N-[2-[4-[[(3S,4S)-4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3-fluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-2-methyl-1,3-oxazole-4-carboxamide?
N-[2-[4-[[(3S,4S)-4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3-fluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-2-methyl-1,3-oxazole-4-carboxamide has a molecular weight of 696.78 g/mol, XLogP of 4.78, 7 rotatable bonds, 2 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[4-[[(3S,4S)-4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]-3-fluoropiperidin-1-yl]methyl]cyclohexyl]indazol-5-yl]-2-methyl-1,3-oxazole-4-carboxamide is sourced from PubChem (CID 176641309), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).